Cadrenal Therapeutics Inc.
Organization details
- Legal name
- Cadrenal Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Ponte Vedra
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CVKD
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001937993
- EIN
- 88-0860746
Board of directors
-
Glynn Wilson · DirectorSince 2023
-
John Raymond Murphy · DirectorSince 2023
-
Lee Scott Golden · DirectorSince 2025
-
Quang X. Pham · Director · Chairman and CEOSince 2023
-
Robert Lisicki · DirectorSince 2023
-
Steven Zelenkofske · DirectorSince 2023
Chief executives
Director election results
Annual meeting of September 24, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.6%
Board connections
3 of this board's directors also sit on 4 other boards. 1 is in the same sector.
- via Glynn Wilson
- via Glynn Wilson
- via John Raymond Murphy
-
Zura Bio Limited Same sectorvia Robert Lisicki
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $457,523
- 23 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 29, 2026 | Quang X. Pham Director, Officer (Chairman and CEO), 10% owner | Open-market sale | −7,400 | $3.03 | $22,422 |
| Jun 26, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −9,029 | $3.05 | $27,538 |
| Jun 25, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −2,127 | $3.00 | $6,381 |
| Jun 23, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −2,277 | $3.20 | $7,286 |
| Jun 22, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −9,167 | $3.55 | $32,543 |
| Jun 17, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −513 | $3.16 | $1,621 |
| Jun 16, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −3,613 | $3.18 | $11,489 |
| Jun 15, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −3,666 | $3.58 | $13,124 |
| Jun 12, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −12,996 | $3.94 | $51,204 |
| Jun 11, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −1,462 | $4.12 | $6,023 |
| Jun 10, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −3,500 | $4.21 | $14,735 |
| Jun 9, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −12,992 | $4.06 | $52,748 |
| Jun 8, 2026 | Quang X. Pham Director, Officer (Chairman, CEO and Interim CFO), 10% owner | Open-market sale | −5,893 | $4.38 | $25,811 |
| Jun 5, 2026 | Quang X. Pham Director, Officer (CEO and Chairman), 10% owner | Open-market sale | −2,064 | $4.42 | $9,123 |
| Jun 4, 2026 | Quang X. Pham Director, Officer (CEO and Chairman), 10% owner | Open-market sale | −3,898 | $4.41 | $17,190 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Cadrenal Therapeutics Inc.
Who is the CEO of Cadrenal Therapeutics Inc.?
Quang X. Pham has been Cadrenal Therapeutics Inc.'s CEO and Chairman since January 2023.
How many directors are on Cadrenal Therapeutics Inc.'s board?
Cadrenal Therapeutics Inc.'s board has 6 directors: Glynn Wilson, John Raymond Murphy, Lee Scott Golden, Quang X. Pham, Robert Lisicki and Steven Zelenkofske.
Are Cadrenal Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Cadrenal Therapeutics Inc. insiders made no open-market purchases and sold $457,523 of shares in 23 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="cadrenal-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.